Search results (129)
« Back to NewsNaveed Akbar awarded International Cardiovascular Research Partnership funding
7 May 2026
Leading mid-career scientists from the UK, France, Germany, and the Netherlands have received almost €6 million from a pioneering partnership between the British Heart Foundation (BHF), the Dutch Heart Foundation (DHF), the German Centre for Cardiovascular Research (DZHK) and the Lefoulon Delalande Foundation (LDF), to support vital international research collaborations work over four years.
Research uncovers new mechanism controlling inflammation in immune cells
29 April 2026
Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.
Pramila Rijal awarded grant from Academy of Medical Sciences Springboard Programme
15 April 2026
Now in its 11th year, Springboard supports researchers at a critical point in their careers, when many are establishing laboratories for the first time and need the freedom to explore ambitious questions.
New AI tool can predict heart failure at least five years before it develops
8 April 2026
Programme uses data from routine CT scans to help doctors identify high-risk patients earlier than ever before
Heavier drinking linked to higher levels of harmful “hidden” fat, study finds
25 March 2026
A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.
Study identifies immune–metabolic pathway as potential target in diabetic heart disease
19 March 2026
Researchers have shown that a drug originally developed to lower blood sugar can improve heart function and reduce inflammation in a preclinical model of type 2 diabetes.
New study reveals how blood cell production responds to parasite infection
11 March 2026
Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
New bone marrow model offers scalable platform for next-generation drug discovery
24 February 2026
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long term blood and immune cell production in a fully human 3D system.
Study suggests blood pressure care after giving birth could protect brain health
19 January 2026
Women who develop high blood pressure during pregnancy may be able to protect their long term brain health through better blood pressure management soon after giving birth, according to a new study by Oxford researchers.
Why the body stops protecting itself against low blood sugar
13 January 2026
New RDM research reveals how prior hypoglycaemia weakens a key hormonal defence.
Night-time changes in metabolism may be driving common liver disease
12 January 2026
Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body is least able to process sugar and fat.
Iron supplement absorption preserved in children with HIV and boosted by prebiotics
13 November 2025
New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.
Oxford scientists map the cells that drive Crohn’s disease fistulas
12 November 2025
Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.
Abdullah Khan receives Wellcome Career Development Award
4 November 2025
Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.
Professor Ellie Tzima receives Leducq Foundation funding to tackle Peripheral Artery Disease
28 September 2025
Professor Ellie Tzima from the Radcliffe Department of Medicine has joined an international team of scientists awarded an $8.5 million grant from the Leducq Foundation to study Peripheral Artery Disease (PAD) and accelerate the development of new therapies.
Oxford University to accelerate type 1 diabetes research and care with £10 million gift
25 September 2025
The University of Oxford has announced a gift of £10 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes (T1D). This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.